PharmaVoice Logo

Healthcare Leaders Hub

Sponsored content

Featured promotional

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer

News

Latest stories

PharmaShots

Sep 4, 2026, 12:30 PM

Samsung Bioepis Reports MHLW Approval of its Ustekinumab Biosimilar

Shots: Ref: Samsung Bioepis |   Image: Samsung Bioepis  |   Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Samsung Bioepis Reports MHLW Approval of its Ustekinumab Biosimilar appeared first on PharmaShots.

Express Pharma

Sep 4, 2026, 11:35 AM

FOPE opposes proposed exemption of retailers, hospitals from DPCO overcharging liability

The Federation of Pharma Entrepreneurs (FOPE) has urged the National Pharmaceutical Pricing Authority (NPPA) to reconsider a reported proposal to exempt retailers, hospitals, nursing homes and other downstream sellers from [
] The post FOPE opposes proposed exemption of retailers, hospitals from DPCO overcharging liability appeared first on Express Pharma.

PharmaShots

Sep 4, 2026, 11:30 AM

Milestone Pharmaceuticals Reports the NMPA Approval of Etripamil Nasal Spray for PSVT

Shots: Ref: Globenewswire  |   Image: Milestone  |   Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Milestone Pharmaceuticals Reports the NMPA Approval of Etripamil Nasal Spray for PSVT appeared first on PharmaShots.

ET Pharma

Sep 4, 2026, 10:42 AM

uniQure seeks US approval for Huntington's gene therapy after FDA reversal

Huntington's disease is a rare inherited brain disorder that causes movement difficulties and triggers behavioural changes and cognitive ‌decline. No approved ⁠drugs ⁠currently exist that help slow progression.

PharmaShots

Sep 4, 2026, 10:30 AM

Globus Medical Receives the CE Mark for Excelsius3D

Shots: Ref: Globenewswire  |   Image:  Globus Medical  |   Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Globus Medical Receives the CE Mark for Excelsius3D appeared first on PharmaShots.

Pharma Tech

Sep 4, 2026, 10:29 AM

Pineapples and green tea: FDA turns to public for new approaches to botanical drugs

The FDA is looking to modernise its regulatory framework for drugs derived from plants, algae, and fungi.

News

Latest industry coverage

Google News

Sep 5, 2026, 8:41 AM

Philippines seeks Bangladesh's cooperation in pharmaceuticals sector - The Business Standard

Philippines seeks Bangladesh's cooperation in pharmaceuticals sector  The Business Standard

Google News

Sep 5, 2026, 8:33 AM

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Given Average Rating of "Moderate Buy" by Analysts  MarketBeat

Google News

Sep 5, 2026, 8:33 AM

3 Indian Pharma Stocks Riding The Export Story Investors Should Watch - simplywall.st

3 Indian Pharma Stocks Riding The Export Story Investors Should Watch  simplywall.st

Google News

Sep 5, 2026, 8:29 AM

AbbVie’s Diversification Bet Gradually Shows Results, While Pfizer Seeks a Second Takeoff Through Its GLP-1 and Oncology Pipelines - NAI500

AbbVie’s Diversification Bet Gradually Shows Results, While Pfizer Seeks a Second Takeoff Through Its GLP-1 and Oncology Pipelines  NAI500

Google News

Sep 5, 2026, 7:42 AM

AbbVie-allied ADARx aims to go public with 3 drugs in the clinic - Endpoints News

AbbVie-allied ADARx aims to go public with 3 drugs in the clinic  Endpoints News

Google News

Sep 5, 2026, 6:55 AM

2026 National Medical Insurance Negotiations Kick Off: Traditional Chinese Medicine Innovators Compete Head-to-Head with Western Drugs, Pre-Negotiation Mechanism Narrows Expectation Gaps - finance.biggo.com

2026 National Medical Insurance Negotiations Kick Off: Traditional Chinese Medicine Innovators Compete Head-to-Head with Western Drugs, Pre-Negotiation Mechanism Narrows Expectation Gaps  finance.biggo.com

Google News

Sep 5, 2026, 6:41 AM

Tarsus Pharmaceuticals Acquires Alkeus, Gildeuretinol for Stargardt Disease - The Clinical Trial Vanguard

Tarsus Pharmaceuticals Acquires Alkeus, Gildeuretinol for Stargardt Disease  The Clinical Trial Vanguard

Google News

Sep 5, 2026, 5:41 AM

RMB 22 billion in capital floods in! Innovative drugs benefit from policy dividends as the wave of business development in the industry continues to heat up. - 毌途牛牛

RMB 22 billion in capital floods in! Innovative drugs benefit from policy dividends as the wave of business development in the industry continues to heat up.  毌途牛牛

Google News

Sep 5, 2026, 2:26 AM

Asia-Pacific Aluminum Crimp-on Seals - Market Analysis, Forecast, Size, Trends and Insights - IndexBox

Asia-Pacific Aluminum Crimp-on Seals - Market Analysis, Forecast, Size, Trends and Insights  IndexBox

Sponsored placement

Featured promotions

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer